We provide you with 20 years of free, institutional-grade data for ALBO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALBO. Explore the full financial landscape of ALBO stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2022-11-08 | 1322505 | ALBO | 10-Q | Url |
2022-08-15 | 1322505 | ALBO | 10-Q | Url |
2022-05-16 | 1322505 | ALBO | 10-Q | Url |
2022-03-01 | 1322505 | ALBO | 10-K | Url |
2021-11-04 | 1322505 | ALBO | 10-Q | Url |
2021-08-05 | 1322505 | ALBO | 10-Q | Url |
2021-05-06 | 1322505 | ALBO | 10-Q | Url |
2021-02-25 | 1322505 | ALBO | 10-K | Url |
2020-11-05 | 1322505 | ALBO | 10-Q | Url |
2020-08-06 | 1322505 | ALBO | 10-Q | Url |
2020-05-07 | 1322505 | ALBO | 10-Q | Url |
2020-03-02 | 1322505 | ALBO | 10-K | Url |
2019-11-06 | 1322505 | ALBO | 10-Q | Url |
2019-08-08 | 1322505 | ALBO | 10-Q | Url |
2019-05-09 | 1322505 | ALBO | 10-Q | Url |
2019-03-06 | 1322505 | ALBO | 10-K | Url |
2018-11-08 | 1322505 | ALBO | 10-Q | Url |
2018-08-09 | 1322505 | ALBO | 10-Q | Url |
2018-05-10 | 1322505 | ALBO | 10-Q | Url |
2018-03-27 | 1322505 | ALBO | 10-K | Url |
2017-11-14 | 1322505 | ALBO | 10-Q | Url |
2017-08-21 | 1322505 | ALBO | 10-Q | Url |
2017-05-11 | 1322505 | ALBO | 10-Q | Url |
2017-03-27 | 1322505 | ALBO | 10-K | Url |
2016-12-22 | 1322505 | ALBO | 10-K | Url |
2016-08-11 | 1322505 | ALBO | 10-Q | Url |
2016-05-10 | 1322505 | ALBO | 10-Q | Url |
2016-02-16 | 1322505 | ALBO | 10-Q | Url |
2015-12-22 | 1322505 | ALBO | 10-K | Url |
2015-08-14 | 1322505 | ALBO | 10-Q | Url |
2015-05-07 | 1322505 | ALBO | 10-Q | Url |
2015-03-19 | 1322505 | ALBO | S-1 | Url |
2015-02-12 | 1322505 | ALBO | 10-Q | Url |
2014-12-19 | 1322505 | ALBO | 10-K | Url |
2014-08-14 | 1322505 | ALBO | S-1 | Url |
2014-08-13 | 1322505 | ALBO | 10-Q | Url |
2014-05-14 | 1322505 | ALBO | 10-Q | Url |
2014-02-10 | 1322505 | ALBO | 10-Q | Url |
2013-12-20 | 1322505 | ALBO | 10-K | Url |
2013-08-14 | 1322505 | ALBO | 10-Q | Url |
2013-05-13 | 1322505 | ALBO | 10-Q | Url |
2013-02-14 | 1322505 | ALBO | 10-Q | Url |
2012-12-21 | 1322505 | ALBO | 10-K | Url |
2012-08-14 | 1322505 | ALBO | 10-Q | Url |
2012-05-15 | 1322505 | ALBO | 10-Q | Url |
2012-02-09 | 1322505 | ALBO | 10-Q | Url |
2011-12-15 | 1322505 | ALBO | 10-K | Url |
2011-08-09 | 1322505 | ALBO | 10-Q | Url |
2011-05-09 | 1322505 | ALBO | 10-Q | Url |
2011-02-07 | 1322505 | ALBO | 10-Q | Url |
2010-12-14 | 1322505 | ALBO | 10-K | Url |
2010-08-06 | 1322505 | ALBO | 10-Q | Url |
2010-05-07 | 1322505 | ALBO | 10-Q | Url |
2010-02-05 | 1322505 | ALBO | 10-Q | Url |
2009-12-14 | 1322505 | ALBO | 10-K | Url |
2009-08-07 | 1322505 | ALBO | 10-Q | Url |
2009-05-08 | 1322505 | ALBO | 10-Q | Url |
2009-02-06 | 1322505 | ALBO | 10-Q | Url |
2008-12-11 | 1322505 | ALBO | 10-K | Url |
2008-08-11 | 1322505 | ALBO | 10-Q | Url |
2008-05-09 | 1322505 | ALBO | 10-Q | Url |
2008-02-14 | 1322505 | ALBO | 10-Q | Url |
2008-01-16 | 1322505 | ALBO | S-1 | Url |
2007-12-21 | 1322505 | ALBO | 10-K | Url |
2007-08-01 | 1322505 | ALBO | 10-Q | Url |
2007-06-15 | 1322505 | ALBO | 10-Q | Url |
2007-02-07 | 1322505 | ALBO | S-1 | Url |
Albireo Pharma, Inc(NASDAQ:ALBO)

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...
Website: http://www.albireopharma.com
Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ALBO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.